Armistice Capital’s iBio IBIO Stock Holding History

Armistice Capital’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-350,877	Closed	-$1.42M	–	319
2024 Q1	$1.42M	Buy	+350,877	New	+$441K	0.02%	151
2023 Q2	–	Sell	-26,282	Closed	-$1.09M	–	249
2023 Q1	$1.09M	Buy	+26,282	New	+$676K	0.02%	136

Other funds holding IBIO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital's IBIO Position: Q2 2024 in Review

Armistice Capital sold out of iBio (IBIO) in Q2 2024, closing a stake of 350,877 shares — an estimated $1.42M sold.

Armistice Capital first reported a position in IBIO in Q1 2023 and held it in 2 quarters. The position peaked at $1.42M in Q1 2024. 28 funds tracked by Wall St. Rank hold IBIO as of Q2 2024.

Armistice Capital reported no remaining iBio position as of Q2 2024 after selling out during the quarter.
Armistice Capital sold 350,877 iBio shares in Q2 2024, an estimated $1.42M.
Armistice Capital first reported a position in iBio in Q1 2023 and held it in 2 quarters.
Armistice Capital's iBio position peaked at $1.42M in Q1 2024.
28 funds tracked by Wall St. Rank held iBio as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.